Biogen could see more upside if it publishes positive results from recent trials linked to kidney and Alzheimer’s treatments, Truist Securities says.
Category: Uncategorized
Here are Monday’s biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Netflix, Deckers, Biogen, Nio & more
Here are Monday’s biggest calls on Wall Street.
American Express is a buy despite its expensive valuation, JPMorgan says
The investment bank upgraded American Express to overweight from neutral.
Kalshi launches ‘Pro’ product for users trading multiple markets at same time, perpetual futures
The platform is designed to alleviate problems the company’s most active traders have run into, according to a memo provided to CNBC.
Hoka’s parent stock has lagged the broader market. Jefferies sees strong gains ahead
The investment firm upgraded the stock to buy from hold.
Top Wall Street analysts are confident about these 3 stocks for the long haul
Those looking for attractive stock picks amid the ongoing volatility can gain key insights by tracking the recommendations of top Wall Street analysts.
Goldman Sachs picks its favorite Chinese AI models
The investment bank released its Chinese AI model competitive positioning framework on Friday.
Earnings playbook: Reporting season gets underway with JPMorgan Chase, Netflix on deck
Nearly 28 S&P 500 companies are set to report earnings this week.
Berkshire Hathaway gains ground, but still trails the S&P 500 as ’26 enters second half
With 2026 a bit more than half over, Berkshire Hathaway’s B shares are down 1.8% year-to-date and 12.4 percentage points behind the S&P 500’s 10.7% gain.
Bank of America says these stocks are a buy heading into earnings
Bank of America named a slew of stocks that are best positioned heading into quarterly reports.